ATE421856T1 - Gebrauch einer ribonuclease der t2-familie mit actin-bindender aktivität zur hemmung und/oder der umkehrung von proliferation - Google Patents

Gebrauch einer ribonuclease der t2-familie mit actin-bindender aktivität zur hemmung und/oder der umkehrung von proliferation

Info

Publication number
ATE421856T1
ATE421856T1 AT00954879T AT00954879T ATE421856T1 AT E421856 T1 ATE421856 T1 AT E421856T1 AT 00954879 T AT00954879 T AT 00954879T AT 00954879 T AT00954879 T AT 00954879T AT E421856 T1 ATE421856 T1 AT E421856T1
Authority
AT
Austria
Prior art keywords
actin
inhibit
binding activity
ribonuclease
family
Prior art date
Application number
AT00954879T
Other languages
English (en)
Inventor
Levava Roiz
Betty Schwartz
Patricia Smirnoff
Oded Shoseyov
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE421856T1 publication Critical patent/ATE421856T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
    • C12Y301/27001—Ribonuclease T2 (3.1.27.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00954879T 1999-08-30 2000-08-29 Gebrauch einer ribonuclease der t2-familie mit actin-bindender aktivität zur hemmung und/oder der umkehrung von proliferation ATE421856T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38541199A 1999-08-30 1999-08-30

Publications (1)

Publication Number Publication Date
ATE421856T1 true ATE421856T1 (de) 2009-02-15

Family

ID=23521271

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954879T ATE421856T1 (de) 1999-08-30 2000-08-29 Gebrauch einer ribonuclease der t2-familie mit actin-bindender aktivität zur hemmung und/oder der umkehrung von proliferation

Country Status (15)

Country Link
EP (3) EP2165605B1 (de)
JP (2) JP4808346B2 (de)
AT (1) ATE421856T1 (de)
AU (1) AU769011B2 (de)
CA (1) CA2382303C (de)
CU (1) CU23065A3 (de)
DE (1) DE60041495D1 (de)
EA (1) EA004929B1 (de)
ES (3) ES2397052T3 (de)
HK (1) HK1045081B (de)
IL (1) IL148345A0 (de)
MX (1) MXPA02002162A (de)
NZ (1) NZ517579A (de)
WO (1) WO2001015531A1 (de)
ZA (1) ZA200201647B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7811981B2 (en) 1999-08-30 2010-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of and compositions for inhibiting the proliferation of mammalian cells
ATE421856T1 (de) * 1999-08-30 2009-02-15 Yissum Res Dev Co Gebrauch einer ribonuclease der t2-familie mit actin-bindender aktivität zur hemmung und/oder der umkehrung von proliferation
ES2524601T3 (es) 2004-09-29 2014-12-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. RNasa T2 humana recombinante y usos de la misma
CZ302164B6 (cs) * 2008-06-20 2010-11-24 Biologické centrum AV CR, v. v. i. Rekombinantní rostlinná nukleáza jako protinádorové terapeutikum s nízkými nežádoucími úcinky
US20160340659A1 (en) 2014-01-30 2016-11-24 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
KR102380296B1 (ko) * 2021-06-15 2022-03-28 롱런 메디칼 푸드 피티이. 엘티디. 기계충버섯(Irpex lacteus) 균사체 배양물 및 이를 유효성분으로 포함하는 당뇨병 예방 및 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786457A (en) * 1989-02-23 1998-07-28 Colorado State University Research Foundation Hormone-nuclease compounds and method for regulating hormone related diseases
ATE421856T1 (de) * 1999-08-30 2009-02-15 Yissum Res Dev Co Gebrauch einer ribonuclease der t2-familie mit actin-bindender aktivität zur hemmung und/oder der umkehrung von proliferation
ES2524601T3 (es) * 2004-09-29 2014-12-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. RNasa T2 humana recombinante y usos de la misma

Also Published As

Publication number Publication date
EP1207755A4 (de) 2004-11-10
AU6722800A (en) 2001-03-26
ZA200201647B (en) 2003-05-28
EA004929B1 (ru) 2004-10-28
HK1045081B (en) 2009-08-07
CU23065A3 (es) 2005-07-19
CA2382303A1 (en) 2001-03-08
WO2001015531A1 (en) 2001-03-08
EA200200312A1 (ru) 2002-10-31
DE60041495D1 (de) 2009-03-19
EP2294918B1 (de) 2012-10-10
JP2003508411A (ja) 2003-03-04
ES2397052T3 (es) 2013-03-04
NZ517579A (en) 2004-02-27
EP1207755B1 (de) 2009-01-28
ES2396998T3 (es) 2013-03-01
JP5467076B2 (ja) 2014-04-09
EP1207755A1 (de) 2002-05-29
HK1045081A1 (en) 2002-11-15
JP4808346B2 (ja) 2011-11-02
HK1157137A1 (en) 2012-06-29
AU769011B2 (en) 2004-01-15
ES2319096T3 (es) 2009-05-04
EP2294918B8 (de) 2012-11-14
EP2294918A1 (de) 2011-03-16
JP2011251971A (ja) 2011-12-15
CA2382303C (en) 2013-02-12
IL148345A0 (en) 2002-09-12
EP2165605B1 (de) 2012-10-10
MXPA02002162A (es) 2002-11-04
EP2165605A1 (de) 2010-03-24

Similar Documents

Publication Publication Date Title
DE69603734D1 (de) Blockcopolymere von Polyolefinen mit Polyurethanen, Copolyestern oder Copolyamiden und ihre Verwendung
DE69431875D1 (de) Anordnung zur bestimmung der gegenseitigen lage von körpern
FI971749L (fi) Lipolyyttistä aktiivisuutta omaava entsyymi
TR27417A (tr) Fungusid aktivitesine sahip bilesik kombinasyonlar.
BR8807886A (pt) Corpo em forma de colmeia, sobretudo com camadas de placas metalicas parcialmente reforcadas em forma de s.
ES2015073B3 (es) Manguito termorretractil que consta de elementos para controlar su calentamiento de forma uniforme, y procedimiento de fabricacion de este manguito.
WO2003030927A3 (fr) Utilisation de peptides analogues de la thymuline (pat) pour la fabrication de medicaments contre la douleur
ATE421856T1 (de) Gebrauch einer ribonuclease der t2-familie mit actin-bindender aktivität zur hemmung und/oder der umkehrung von proliferation
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
AT399530B (de) Flachschlüssel und bzw. oder schliesszylinder
DE69810762T8 (de) Algizides und fungizides konservierungsmittel mit alternaria-aktivität
ATA4096A (de) Schliesszylinder und bzw. oder flachschlüssel
ATE301194T1 (de) Beta-defensine
ES1022605Y (es) Funda universal para revestir sillones, sofas y similares.
DE60011949D1 (de) Verriegelungsbeschlag des Typs mit Treibstangen oder ähnlichem
DK526985A (da) Polycykliske biocide forbindelser, deres fremstilling og mellemprodukter herved samt deres anvendelse i medicinske praeparationer
FI940999L (fi) Piperidin-2-alkyylikarboksylaattien entsymaattinen toisiintuminen ja saatujen yhdisteiden käyttö synteesin välituotteina
DE3881122D1 (de) Klonierung einer fuer einen antibakteriellen polypeptid-vorlaeufer kodierenden dns und expression dieses vorlaeufers.
DE69837789D1 (de) Kontrolle der pflanzlichen abszission und schotendehiszenz oder schotenabwurfs
ATA126985A (de) Mindestens zu zweit zu verwendender stapelstaender fuer stapel von laenglichen und/oder flaechigen gegenstaenden, wie schaltafeln, kanthoelzer, bretter od.dgl.
FI960342L (fi) Bentsoksatsinonit ja bentsotiatsinonit, joilla on terapeuttista aktiivisuutta
WO2000021508A3 (fr) Nouvelle utilisation therapeutique de composes a activite beta-3-agoniste
ES2113647T3 (es) Composicion.
ITRM930845A0 (it) Peptide ad attivita' di substrato e/o inibitore dell'enzima transglutaminasi e suo uso in giagnosi e terapia.
IT210233Z2 (it) Struttura di maniglia per pentole e simili con protezione contro le scottature accidentali.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties